WHO Releases First GLP-1 Obesity Treatment Guideline, Signaling New Opportunities for the Global Pharma IndustryThe World Health Organization (WHO) has issued its first global guid...

Can You Drink Alcohol While Taking Targeted Therapy Drugs? Doctors Explain Why It’s Not RecommendedOne of the most common questions from cancer patients is:'Can I drink a little a...

 Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...

With the rapid development of precision medicine, targeted drugs have become a key approach in cancer treatment. Unlike traditional chemotherapy, targeted therapy “hits” specific...

The Global Cancer Landscape: From First- to Third-Generation Targeted Drugs — How Medicine Is Changing the Fate of CancerNot long ago, a cancer diagnosis was almost a death senten...

Treatment of type 1 diabetes (T1D) is entering a transformative era. The first immunotherapy approved to delay clinical onset—Teplizumab—has received FDA approval in the United S...

Many patients say: 'After taking targeted therapy, my tumor shrank, and I feel better. Does this mean I’m cured?' This is a common misconception.Targeted Therapy: Control, Not Com...

Pharmacil is a key pharmaceutical company under the Radiant Group in Bangladesh. Established in 2005 and headquartered in Dhaka, Bangladesh, it boasts modern pharmaceutical prod...

Breast cancer remains the most commonly diagnosed cancer among women worldwide. Although its发病 trends and risk factors have been extensively studied, public understanding of how ...

ProstACT Global Phase 3 Update: First Patient Dosed, Part 1 Preliminary Data Plans ConfirmedTelix recently announced that its lead prostate cancer candidate TLX591 (lutetium-177 ro...